168 related articles for article (PubMed ID: 11994043)
1. The practice of splitting tablets: cost and therapeutic aspects.
Bachynsky J; Wiens C; Melnychuk K
Pharmacoeconomics; 2002; 20(5):339-46. PubMed ID: 11994043
[TBL] [Abstract][Full Text] [Related]
2. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.
Hamer AM; Hartung DM; Haxby DG; Ketchum KL; Pollack DA
J Manag Care Pharm; 2006; 12(6):449-56. PubMed ID: 16925452
[TBL] [Abstract][Full Text] [Related]
3. Potential savings from splitting newer antidepressant medications.
Cohen CI; Cohen SI
CNS Drugs; 2002; 16(5):353-8. PubMed ID: 11994024
[TBL] [Abstract][Full Text] [Related]
4. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry.
Ciavarella AB; Khan MA; Gupta A; Faustino PJ
PDA J Pharm Sci Technol; 2016 11/12; 70(6):523-532. PubMed ID: 27974592
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of tablet splitting: Comparison study between hand splitting and tablet cutter.
Habib WA; Alanizi AS; Abdelhamid MM; Alanizi FK
Saudi Pharm J; 2014 Nov; 22(5):454-9. PubMed ID: 25473334
[TBL] [Abstract][Full Text] [Related]
6. The potential of pill splitting to achieve cost savings.
Stafford RS; Radley DC
Am J Manag Care; 2002 Aug; 8(8):706-12. PubMed ID: 12212758
[TBL] [Abstract][Full Text] [Related]
7. Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice.
Tahaineh LM; Gharaibeh SF
J Pharm Pract; 2012 Aug; 25(4):471-6. PubMed ID: 22544621
[TBL] [Abstract][Full Text] [Related]
8. Tablet splitting of narrow therapeutic index drugs: a nationwide survey in Taiwan.
Chou CL; Hsu CC; Chou CY; Chen TJ; Chou LF; Chou YC
Int J Clin Pharm; 2015 Dec; 37(6):1235-41. PubMed ID: 26399507
[TBL] [Abstract][Full Text] [Related]
9. Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting.
Helmy SA
J Manag Care Spec Pharm; 2015 Jan; 21(1):76-86. PubMed ID: 25562775
[TBL] [Abstract][Full Text] [Related]
10. [Tablet splitting].
Quinzler R; Haefeli WE
Ther Umsch; 2006 Jun; 63(6):441-7. PubMed ID: 16841582
[TBL] [Abstract][Full Text] [Related]
11. Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance.
Fawell NG; Cookson TL; Scranton SS
Am J Health Syst Pharm; 1999 Dec; 56(24):2542-5. PubMed ID: 10613374
[TBL] [Abstract][Full Text] [Related]
12. Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis.
Dormuth CR; Schneeweiss S; Brookhart AM; Carney G; Bassett K; Adams S; Wright JM
Open Med; 2008; 2(3):e74-82. PubMed ID: 21602952
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Certain Pharmaceutical Quality Attributes of Lisinopril Split Tablets.
Fahelelbom KM; Al-Tabakha MM; Eissa NA; Javadi J
Sci Pharm; 2016 Oct; 84(4):646-653. PubMed ID: 27727195
[TBL] [Abstract][Full Text] [Related]
14. Cost-Savings From an Antipsychotic Tablet-Splitting Program.
Carey H; Fondriest M
P T; 2017 Jun; 42(6):384-393. PubMed ID: 28579725
[TBL] [Abstract][Full Text] [Related]
15. Tablet splitting: a review of weight and content uniformity.
Freeman MK; White W; Iranikhah M
Consult Pharm; 2012 May; 27(5):341-52. PubMed ID: 22591978
[TBL] [Abstract][Full Text] [Related]
16. Tablet splitting: a review of the clinical and economic outcomes and patient acceptance. Second of a 2-part series. Part 1 was published in May 2012 (Consult Pharm 2012;27:239-53).
Freeman MK; White W; Iranikhah M
Consult Pharm; 2012 Jun; 27(6):421-30. PubMed ID: 22698549
[TBL] [Abstract][Full Text] [Related]
17. Concerns regarding tablet splitting: a systematic review.
Saran AK; Holden NA; Garrison SR
BJGP Open; 2022 Sep; 6(3):. PubMed ID: 35193886
[TBL] [Abstract][Full Text] [Related]
18. The frequency of inappropriate tablet splitting in primary care.
Quinzler R; Gasse C; Schneider A; Kaufmann-Kolle P; Szecsenyi J; Haefeli WE
Eur J Clin Pharmacol; 2006 Dec; 62(12):1065-73. PubMed ID: 17024485
[TBL] [Abstract][Full Text] [Related]
19. Weight uniformity of split tablets required by a Veterans Affairs policy.
Polli JE; Kim S; Martin BR
J Manag Care Pharm; 2003; 9(5):401-7. PubMed ID: 14613437
[TBL] [Abstract][Full Text] [Related]
20. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets.
Cook TJ; Edwards S; Gyemah C; Shah M; Shah I; Fox T
J Am Pharm Assoc (2003); 2004; 44(5):583-6. PubMed ID: 15496044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
